The microtiter plate is a standard tool in analytical research and diagnostic testing laboratories. SphingoTec’s microtiter plate assays are based on a chemiluminescence sandwich immunoassay technology. SphingoTec's proprietary biomarkers are available as CE-IVD microtiter plate assays, including the assay for penKid, bio-ADM.
SphingoTec develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, outcome prediction and monitoring of acute medical conditions, such as sepsis, acute heart failure, circulatory shock, and acute kidney injury. In addition, SphingoTec develops a portfolio of novel biomarkers, which predict the risks of developing obesity, breast cancer and cardiovascular diseases. IVD tests for SphingoTec’s proprietary biomarkers are made available as sphingotest® microtiterplate tests.
Do you have any questions about our services?
Our dedicated Team can help you.
Please fill in the form and we will be in touch with you shortly.